Arteaga, Carlos L
- Vanderbilt University Medical Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #23,753
- Sustained Excellence
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$510.3K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#23,753
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Arteaga, Carlos L as a PI. Multi-PI records show the full award amount for context.
- 1R01CA273246-01A1R01Contact PINeoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer$510.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Arteaga, Carlos L as a PI.
FY2023 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardVanderbilt University Medical Center
- 2001$500K Cumulative Funding
- 2001Entered Top 50% NationallyRanked #4365
- 2001Entered Top 25% NationallyRanked #4365
- 2002$1M Cumulative Funding
- 2003$2M Cumulative Funding
- 2003$5M Cumulative Funding
- 2003Entered Top 10% NationallyRanked #474
- 2003Entered Top 5% NationallyRanked #474
- 2003R01 Grant Holder
- 2005$10M Cumulative Funding